[go: up one dir, main page]

GB2048250B - 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses - Google Patents

2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses

Info

Publication number
GB2048250B
GB2048250B GB8008979A GB8008979A GB2048250B GB 2048250 B GB2048250 B GB 2048250B GB 8008979 A GB8008979 A GB 8008979A GB 8008979 A GB8008979 A GB 8008979A GB 2048250 B GB2048250 B GB 2048250B
Authority
GB
United Kingdom
Prior art keywords
pyrimidinols
aryl
amino
pharmaceutical uses
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8008979A
Other versions
GB2048250A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB2048250A publication Critical patent/GB2048250A/en
Application granted granted Critical
Publication of GB2048250B publication Critical patent/GB2048250B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB8008979A 1979-03-19 1980-03-17 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses Expired GB2048250B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2220579A 1979-03-19 1979-03-19
US7985079A 1979-09-28 1979-09-28

Publications (2)

Publication Number Publication Date
GB2048250A GB2048250A (en) 1980-12-10
GB2048250B true GB2048250B (en) 1983-04-27

Family

ID=26695670

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8008979A Expired GB2048250B (en) 1979-03-19 1980-03-17 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses

Country Status (7)

Country Link
JP (1) JPH0627070B2 (en)
CH (1) CH646958A5 (en)
DE (1) DE3008693A1 (en)
FR (1) FR2451918A1 (en)
GB (1) GB2048250B (en)
IT (1) IT1143012B (en)
NL (1) NL8001568A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111440A1 (en) * 1982-10-15 1984-06-20 Ciba-Geigy Ag 2-Aminopyrimidines, their production and use
US4795812A (en) * 1985-02-05 1989-01-03 The Upjohn Company 4-substituted-6-aryl-pyrimidine compounds
GB9012311D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
JP2001505911A (en) * 1996-12-12 2001-05-08 ファルマシア・アンド・アップジョン・カンパニー How to treat multiple sclerosis
US6495558B1 (en) 1999-01-22 2002-12-17 Amgen Inc. Kinase inhibitors
EP1144390A2 (en) * 1999-01-22 2001-10-17 Amgen Inc., Kinase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2688019A (en) * 1951-08-25 1954-08-31 Burroughs Wellcome Co 6-aryl-2,4-diamino pyrimidines and process of preparing same
US2723977A (en) * 1953-07-29 1955-11-15 Searle & Co 5, 6-disubstituted 2-amino-4-pyrimidols
US2723978A (en) * 1954-01-14 1955-11-15 Searle & Co 2-amino-5-alkenyl-6-phenyl-4-pyrimidols
US2710867A (en) * 1954-03-12 1955-06-14 Searle & Co New 2-amino-4-pyrimidol derivatives
US2748121A (en) * 1954-06-17 1956-05-29 Searle & Co 6-nitroaryl derivatives of 2-amino-4-pyrimidols
US2704285A (en) * 1954-06-17 1955-03-15 Searle & Co 2-amino-5-(lower alkyl)-6-substituted phenyl-4-pyrimidols
US3281420A (en) * 1966-01-27 1966-10-25 Searle & Co Carboxylic acid [2-(2-amino-4-azido-6-phenyl-5-pyrimidinyl)-1-methylethylidene] hydrazides and intermediate
US3412094A (en) * 1967-06-21 1968-11-19 Searle & Co 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners
US3932617A (en) * 1974-05-24 1976-01-13 The Upjohn Company Interferon induction

Also Published As

Publication number Publication date
JPH0627070B2 (en) 1994-04-13
GB2048250A (en) 1980-12-10
NL8001568A (en) 1980-09-23
FR2451918A1 (en) 1980-10-17
IT1143012B (en) 1986-10-22
CH646958A5 (en) 1984-12-28
IT8048119A0 (en) 1980-03-10
DE3008693A1 (en) 1980-10-02
FR2451918B1 (en) 1984-01-06
JPH0517451A (en) 1993-01-26

Similar Documents

Publication Publication Date Title
GB2055800B (en) Guanidinothiazoles and their preparation and use
GB2103591B (en) Pharmaceutical compositions and process
PH18683A (en) Novel 4-aroylimidazol-2-ones and their use
GB2053210B (en) Substituted 3-arylpyrazoles and 5-arylisoxazoles
GB2065631B (en) Despersant and biodegradant formulations
JPS55100313A (en) Drug composition and its manufacture
JPS5663957A (en) Nnazidosulfonylaryllmaleinimide and its use
IL60873A0 (en) 4-fluoro-3-phenoxy-benzylethers and their preparation
GB2052488B (en) 3 - vinyl - cephalosporins and their preparation
JPS565207A (en) Tireeliner and its preparation
JPS56124651A (en) Lockerrhousing and lockerrcover
GB2051062B (en) 3-vinyl-cephalosporin derivatives and their preparation
JPS5640680A (en) 33methyleneflavanone and 33methylenechromanone and their use
JPS55154994A (en) Amtibiotic aa6888c and aa6888x
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
JPS55162784A (en) Hydroxyaminooeburnane derivatives and their manufacture
GB2048250B (en) 2-amino-6-aryl-4-pyrimidinols and their pharmaceutical uses
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
JPS5616441A (en) 44fluoroo33bromoobenzoylfluoride and manufacture thereof
JPS55130950A (en) Betaaalkoxyyacrylonitrile*33aminooacryonitrile and 22cyanoovinylester manufacture
IL60541A0 (en) Tallysomicin derivatives and their preparation
CY1334A (en) 17-cycloalkylmethyl-6-methylene-morphinane derivatives and their preparation
JPS5687570A (en) Isoureas and their use
ZA80273B (en) 4-phenylthioalkanesulfonanilides and derivatives thereof
JPS5629556A (en) Substituted trichloropropylureas and their use

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20000316